| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Zileuton |
Is a |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Diprophylline |
Is a |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Deproteinated pancreatic extract (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Thiphenamyl |
Is a |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Ambuphylline |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Sildenafil (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Papaverine (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Genitourinary smooth muscle relaxant |
Is a |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Gastrointestinal smooth muscle relaxant (substance) |
Is a |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing zafirlukast (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing leukotriene receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Smooth muscle relaxant poisoning |
Causative agent (attribute) |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
1 |
| Adiphenine poisoning |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Smooth muscle relaxant poisoning NOS |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Smooth muscle relaxant adverse reaction (disorder) |
Causative agent (attribute) |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
1 |
| Smooth muscle relaxant allergy |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Smooth muscle relaxant overdose |
Causative agent (attribute) |
True |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
1 |
| Aminophylline 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophylline 25 mg/mL, ampoule de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Aminophylline 225mg modified release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Aminophylline 350mg modified release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Aminophylline 100mg modified release tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| aminophylline 25 mg/mL, seringue préremplie de 10 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Oxtriphylline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 10mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline monohydrate (as theophylline sodium glycinate) 12 milligram/1 milliliter conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 175mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 250mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 60mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 125mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 250mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 200mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 300mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 400mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Ephedrine hydrochloride 11 mg and theophylline 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Ephedrine sulfate 15 mg and theophylline 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing montelukast (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely montelukast (as montelukast sodium) 5 milligram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Zafirlukast 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Aminophylline-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Aminophylline-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Poisoning by smooth muscle relaxant |
Causative agent (attribute) |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Dyphylline 125mg/mL injection solution 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Dyphylline 160mg/15ml elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Zafirlukast 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline anhydrous 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline anhydrous 200 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline anhydrous 300 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline anhydrous 400 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 80mg/15mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline anhydrous 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Dyphylline 100mg/15mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Diprophylline 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 50mg/1mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Diprophylline 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 400mg/10 mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 800 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline anhydrous 50 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Montelukast sodium 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Montelukast sodium 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 100mg/5mL oral liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 100mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline anhydrous 450mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely guaifenesin 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline 75 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 675 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 575 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline anhydrous 300mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline, anhydrous 80mg/15mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline anhydrous 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Theophylline 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Montelukast sodium 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Dyphylline + guaifenesin 100mg/100mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Dyphylline + guaifenesin 100mg/100mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Dyphylline + guaifenesin 100mg/100mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Diprophylline 100 mg and guaifenesin 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Dyphylline + guaifenesin 100mg/50mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Diprophylline 200 mg and guaifenesin 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Diprophylline 200 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin + oxtriphylline 50mg/100mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin + oxtriphylline 50mg/100mg elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin + theophylline 100mg/150mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin + theophylline 100mg/80mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin + theophylline 200mg/150mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
| Guaifenesin + theophylline 90mg/150mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Smooth muscle relaxant (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]